News EU regulator begins publishing detailed study data European Medicines Agency proactively publishes clinical study reports for first time.
News UK aims to cut four years from drug development process NICE, regulator and NHS should work together, according to review.
News Lilly's Lartruvo approved in US for soft tissue sarcoma Eli Lilly’s 'breakthrough' drug for soft tissue sarcoma, Lartruvo, has been approved by the FDA.
News The end for Theranos? Company closes labs and cuts workforce Company will now focus solely on its miniLab technology.
News New breakthrough designations for Roche's Alecensa and Actem... Alecensa and Roactemra are breakthroughs, says FDA.
News Faron moves ahead with "shock lung" drug Finnish firm eyes first drug for acute respiratory distress syndrome.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
